Full functional activity of SSL7 requires binding of both complement C5 and IgA

Immunology and Cell Biology

Volumn 91, Issue 7, 2013, Pages 469-476

  Lorenz, Natalie ^a   Clow, Fiona ^a   Radcliff, Fiona J ^a   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

complement C5; immune evasion; immunoglobulin A; staphylococcal superantigen like

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN A; STAPHYLOCOCCAL SUPERANTIGEN LIKE PROTEIN 7; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BINDING SITE; BONE MARROW CELL; CELL MIGRATION; CELL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LACTOCOCCUS LACTIS; MOUSE; MUTAGENESIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CELL MOVEMENT; CELLS, CULTURED; COMPLEMENT C5; EXOTOXINS; GENETIC ENGINEERING; HUMANS; IMMUNE EVASION; IMMUNOGLOBULIN A; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; MUTATION; NEUTROPHILS; PROTEIN BINDING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSGENES; VIRULENCE FACTORS;

EID: 84881417024     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.28     Document Type: Article

References (38)

1. Noble WC, Valkenburg HA, Wolters CH. Carriage of Staphylococcus aureus in random samples of a normal population. J Hyg (Lond) 1967; 65: 567-573.
2. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46(Suppl 5); S350-S359. (Pubitemid 351717322)
3. Casewell MW, Hill RL. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986; 18(Suppl A); 1-12. (Pubitemid 16038217)
4. Klos A, Tenner AJ, Johswich K-O, Ager RR, Reis ES, Köhl J. The role of the anaphylatoxins in health and disease. Mol Immunol 2009; 46: 2753-2766.
5. Rosado CJ, Kondos S, Bull TE, Kuiper MJ, Law RHP, Buckle AM et al. The MACPF/CDC family of pore-forming toxins. Cell Microbiol 2008; 10: 1765-1774.
6. Rooijakkers SHM, van Strijp JAG. Bacterial complement evasion. Mol Immunol 2007; 44: 23-32. (Pubitemid 44647108)
7. Rooijakkers SHM, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005; 6: 920-927. (Pubitemid 43090447)
8. de Haas CJC, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJB, Heezius ECJM et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflam-matory agent. J Exp Med 2004; 199: 687-695. (Pubitemid 38316435)
9. Rooijakkers SHM, Ruyken M, Van Roon J, Van Kessel KPM, van Strijp JAG, Van Wamel WJB. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol 2006; 8: 1282-1293.
10. Langley R, Patel D, Jackson N, Clow F, Fraser JD. Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol 2010; 30: 149-165.
11. Langley RJ, Wines B, Willoughby N, Basu I, Proft T, Fraser JD. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol 2005; 174: 2926-2933. (Pubitemid 40279711)
12. Itoh S, Hamada E, Kamoshida G, Yokoyama R, Takii T, Onozaki K et al. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol 2010; 47: 932-938.
13. Patel D, Wines BD, Langley RJ, Fraser JD. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J. Immunol. 2010; 184: 6283-6292.
14. Hermans SJ, Baker HM, Sequeira RP, Langley RJ, Baker EN, Fraser JD. Structural and functional properties of staphylococcal superantigen-like protein 4. Infect Immun 2012; 80: 4004-4013.
15. Bestebroer J, Poppelier MJJG, Ulfman LH, Lenting PJ, Denis CV, Van Kessel KPM et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 2007; 109: 2936-2943. (Pubitemid 46482091)
16. Baker HM, Basu I, Chung MC, Caradoc-Davies T, Fraser JD, Baker EN. Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol 2007; 374: 1298-1308. (Pubitemid 350122541)
17. Chung MC, Wines BD, Baker HM, Langley RJ, Baker EN, Fraser JD. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol 2007; 66: 1342-1355. (Pubitemid 350179672)
18. Bardoel BW, Vos R, Bouman T, Aerts PC, Bestebroer J, Huizinga EG et al. Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med (Berl) 2012; 90: 1109-1120.
19. Yokoyama R, Itoh S, Kamoshida G, Takii T, Fujii S, Tsuji T et al. Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun 2012; 80: 2816-2825.
20. Benson MA, Lilo S, Wasserman GA, Thoendel M, Smith A, Horswill AR et al. Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol 2011; 81: 659-675.
21. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J et al. A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe 2007; 1: 109-119. (Pubitemid 46554913)
22. Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci USA 2007; 104: 15051-15056. (Pubitemid 47619591)
23. Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B et al. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci 2010; 107: 3681-3686.
24. Bestebroer J, Aerts PC, Rooijakkers SH, Pandey MK, Kohl J, van Strijp JA et al. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell Microbiol 2010; 12: 1506-1516.
25. Casalta E, Montel M-C. Safety assessment of dairy microorganisms: the Lactococcus genus. Int J Food Microbiol 2008; 126: 271-273.
26. Bahey-El-Din M, Gahan CGM, Griffin BT. Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Curr Gene Ther 2010; 10: 34-45.
27. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Micro 2008; 6: 132-142.
28. Joiner K, Brown EL, Hammer C, Warren K, Frank MM. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. J Immunol 1983; 130: 845-849. (Pubitemid 13186316)
29. Laursen NS, Andersen KR, Braren I, Spillner E, Sottrup-Jensen L, Andersen GR. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex. EMBO J 2011; 30: 606-616.
30. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006; 208: 270-282. (Pubitemid 43126119)
31. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003; 293: 3-15. (Pubitemid 36534594)
32. Haas P-J, de Haas CJC, Poppelier MJJC, Van Kessel KPM, Van Strijp JAG, Dijkstra K et al. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. J Mol Biol 2005; 353: 859-872. (Pubitemid 41457387)
33. Jongerius I, Köhl J, Pandey MK, Ruyken M, Van Kessel KPM, Van Strijp JAG et al. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007; 204: 2461-2471. (Pubitemid 47529330)
34. Cheung AL, Koomey JM, Butler CA, Projan SJ, Fischetti VA. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci USA 1992; 89: 6462-6466.
35. Chang A, Khemlani A, Kang H, Proft T. Functional analysis of Streptococcus pyogenes nuclease A (SpnA), a novel group A streptococcal virulence factor. Molecular Microbiology 2011; 79: 1629-1642.
36. Hudson KR, Robinson H, Fraser JD. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity. J Exp Med 1993; 177: 175-184. (Pubitemid 23008097)
37. Alvarez-García E, Alegre-Cebollada J, Batanero E, Monedero V, Pérez-Martínez G, García-Fernández R et al. Lactococcus lactis as a vehicle for the heterologous expression of fungal ribotoxin variants with reduced IgE-binding affinity. J Biotechnol 2008; 134: 1-8.
38. Heit B, Colarusso P, Kubes P. Fundamentally different roles for LFA-1, Mac-1 and alpha4-integrin in neutrophil chemotaxis. J Cell Sci 2005; 118: 5205-5220. (Pubitemid 41819584)